Literature DB >> 26370200

Risk factors for pulmonary embolism in patients preliminarily diagnosed with community-acquired pneumonia: a prospective cohort study.

Yunfeng Zhang1, Qixing Zhou1, Ying Zou1, Xiaolian Song2, Shuanshuan Xie2, Min Tan2, Guoliang Zhang2, Changhui Wang3.   

Abstract

D-dimer levels are increased in patients with acute pulmonary embolism (PE). However, D-dimer levels are also increased in patients with community-acquired pneumonia (CAP). The aim of this prospective cohort study was to examine the incidence and clinical features of patients preliminarily diagnosed with CAP and with increased D-dimer levels, and who finally were diagnosed with PE. Patients diagnosed with CAP and hospitalized in the Respiratory Department of the Tenth People's Hospital Affiliated to Tongji University between May 2011 and May 2013 were enrolled. D-dimer levels were measured routinely after admission. For patients with increased D-dimer levels, those suspected with PE underwent computed tomography pulmonary angiography (CTPA). A total of 2387 patients with CAP was included: 724 (30.3 %) had increased D-dimer levels (median of 0.91 mg/L). CTPA was performed for 139 of the 724 patients (median D-dimer levels of 1.99 mg/L). Among the 139 patients, 80 were diagnosed with PE, and 59 without PE; D-dimer levels were 2.83 and 1.41 mg/L, respectively (p < 0.05). Multivariate analysis showed that age, coronary heart disease, chronic obstructive pulmonary disease (COPD), lower limb varicosity, chest pain, shortness of breath, hemoptysis, fever, and increased levels of troponin I were independent risk factors for PE. Presentation of PE and CAP are similar. Nevertheless, these results indicated that for hospitalized patients with CAP and elevated D-dimer levels, PE should be considered for those >60 years; with CHD, COPD, or lower limb varicosity; with chest pain, shortness of breath, hemoptysis, increased troponin I, or low fever.

Entities:  

Keywords:  Community-acquired pneumonia; Complications; D-dimer; Prospective cohort study; Pulmonary thromboembolism; Risk factors

Mesh:

Substances:

Year:  2016        PMID: 26370200     DOI: 10.1007/s11239-015-1275-6

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  27 in total

Review 1.  DVT and pulmonary embolism: Part I. Diagnosis.

Authors:  Dino W Ramzi; Kenneth V Leeper
Journal:  Am Fam Physician       Date:  2004-06-15       Impact factor: 3.292

2.  D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial.

Authors:  Dominic Snijders; Margreet Schoorl; Marianne Schoorl; Piet C Bartels; Tjip S van der Werf; Wim G Boersma
Journal:  Eur J Intern Med       Date:  2011-11-21       Impact factor: 4.487

3.  D-dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE Registry.

Authors:  J L Lobo; V Zorrilla; F Aizpuru; E Grau; D Jiménez; G Palareti; M Monreal
Journal:  J Thromb Haemost       Date:  2009-08-19       Impact factor: 5.824

Review 4.  The role of qualitative D-dimer assays, clinical probability, and noninvasive imaging tests for the diagnosis of deep vein thrombosis and pulmonary embolism.

Authors:  Philip S Wells
Journal:  Semin Vasc Med       Date:  2005-11

5.  Elevated D-dimer levels signify overlap between community-acquired pneumonia and pulmonary embolism.

Authors:  Oscar M P Jolobe
Journal:  Eur J Intern Med       Date:  2012-08-21       Impact factor: 4.487

6.  Prevalence of deep venous thrombosis in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Sheng-chen Duan; Yuan-hua Yang; Xu-yan Li; Xiao-ning Liang; Rui-jun Guo; Wan-mu Xie; Tu-guang Kuang; Hua-ping Dai; Chen Wang
Journal:  Chin Med J (Engl)       Date:  2010-06       Impact factor: 2.628

7.  Time trends in pulmonary embolism in the United States: evidence of overdiagnosis.

Authors:  Renda Soylemez Wiener; Lisa M Schwartz; Steven Woloshin
Journal:  Arch Intern Med       Date:  2011-05-09

8.  Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease?

Authors:  Olivier T Rutschmann; Jacques Cornuz; Pierre-Alexandre Poletti; Pierre-Olivier Bridevaux; Olivier W Hugli; Salah D Qanadli; Arnaud Perrier
Journal:  Thorax       Date:  2006-11-13       Impact factor: 9.139

Review 9.  D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review.

Authors:  Paul D Stein; Russell D Hull; Kalpesh C Patel; Ronald E Olson; William A Ghali; Rollin Brant; Rita K Biel; Vinay Bharadia; Neeraj K Kalra
Journal:  Ann Intern Med       Date:  2004-04-20       Impact factor: 25.391

10.  Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population.

Authors:  Holly Yu; Jaime Rubin; Stephan Dunning; Suying Li; Reiko Sato
Journal:  J Am Geriatr Soc       Date:  2012-10-30       Impact factor: 5.562

View more
  8 in total

Review 1.  Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians.

Authors:  Eduardo Vazquez-Garza; Carlos Jerjes-Sanchez; Aline Navarrete; Jorge Joya-Harrison; David Rodriguez
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

2.  Clinical characteristics and risk factors predictive of pulmonary embolism complicated in bronchiectasis patients: a retrospective study.

Authors:  Tiantian Deng; Ke Xu; Beishou Wu; Fei Sheng; Xu Li; Zhuxian Zhu; Ziqiang Zhang
Journal:  BMC Pulm Med       Date:  2022-06-09       Impact factor: 3.320

3.  Anatomic and clinical risk factors for pulmonary embolism in patients with deep venous thrombosis of the lower extremity.

Authors:  Bomina Paik; Jin Hyun Joh; Ho-Chul Park
Journal:  Ann Surg Treat Res       Date:  2017-04-27       Impact factor: 1.859

4.  Differences between surviving and non-surviving venous thromboembolism COVID-19 patients: a systematic review.

Authors:  Mauricio Castillo-Perez; Carlos Jerjes-Sanchez; Alejandra Castro-Varela; Jose Gildardo Paredes-Vazquez; Eduardo Vazquez-Garza; Ray Erick Ramos-Cazares; Jose Alfredo Salinas-Casanova; Abigail Montserrat Molina-Rodriguez; Arturo Adrián Martinez-Ibarra; Mario Alejandro Fabiani; Yoezer Z Flores-Sayavedra; Jaime Alberto Guajardo-Lozano; Hector Lopez-de la Garza; Hector Betancourt-Del Campo; Daniela Martinez-Magallanes; Jathniel Panneflek
Journal:  Thromb J       Date:  2021-12-15

5.  Infrared Spectroscopy in Differential Diagnosis of Pulmonary Embolism.

Authors:  O V Krasnikova; S V Nemirova; A P Medvedev; A S Gordetsov
Journal:  Sovrem Tekhnologii Med       Date:  2020-06-28

6.  Value of D-dimer in predicting various clinical outcomes following community-acquired pneumonia: A network meta-analysis.

Authors:  Jiawen Li; Kaiyu Zhou; Hongyu Duan; Peng Yue; Xiaolan Zheng; Lei Liu; Hongyu Liao; Jinlin Wu; Jinhui Li; Yimin Hua; Yifei Li
Journal:  PLoS One       Date:  2022-02-23       Impact factor: 3.240

7.  Pulmonary Embolism in Pneumonia: Still a Diagnostic Challenge? Results of a Case-Control Study in 100 Patients.

Authors:  Maria Paparoupa; Loukia Spineli; Theodor Framke; Huy Ho; Frank Schuppert; Adrian Gillissen
Journal:  Dis Markers       Date:  2016-05-25       Impact factor: 3.434

8.  Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective study.

Authors:  Alberto Alonso-Fernández; Nuria Toledo-Pons; Borja G Cosío; Aina Millán; Néstor Calvo; Luisa Ramón; Sara Hermoso de Mendoza; Daniel Morell-García; Josep Miquel Bauça-Rossello; Belén Núñez; Jaume Pons; Juan A Palmer; Luisa Martín; María Peñaranda; Joan A Pou; Jaume Sauleda; Ernest Sala-Llinas
Journal:  PLoS One       Date:  2020-08-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.